Icagen to Present At the 10th Annual BIO CEO and Investor Conference On February 12, 2008
05 févr. 2008 08h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Feb. 5, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 10th Annual BIO CEO and Investor Conference...
Icagen Provides Update for Clinical Development of Senicapoc, a Novel Oral Small Molecule Ion Channel Blocker
08 janv. 2008 09h41 HE
|
Icagen, Inc.
FDA Accepts Icagen's IND for Senicapoc as a Potential Treatment
for Asthma
Dosing to Begin in Phase Ib Clinical Trial During January
RESEARCH TRIANGLE PARK,...
Icagen to Present At the JPMorgan Healthcare Conference On January 10, 2008
03 janv. 2008 07h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 3, 2008 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that executive management will participate in the 26th Annual JPMorgan Healthcare Conference...
Icagen to Present At the Acumen BioFin Rodman & Renshaw Healthcare Conference On November 6, 2007
30 oct. 2007 16h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2007 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that P. Kay Wagoner, Ph.D., President and Chief Executive Officer, and Richard D. Katz, M.D.,...
Icagen to Present At the Annual Meeting of the Society for Neuroscience On November 5, 2007
29 oct. 2007 16h30 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 29, 2007 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that Dr. Neil Castle, Director of Biology at Icagen, and Dr. Aaron Gerlach, Ph.D., Senior...
Icagen to Announce Third Quarter 2007 Results and Conduct Conference Call On November 2, 2007
25 oct. 2007 16h57 HE
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 25, 2007 (PRIME NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release third quarter 2007 financial results on Friday, November 2, 2007. The...